While anti-VEGF injections are widely used to treat patients with wet age-related macular degeneration (AMD), there have been limited treatment options available for dry AMD other than AREDS vitamin formulations and lifestyle modifications.
In the latest episode of “Blind Spot – The Eye Doctor’s Podcast,” Texas Retina’s Ashkan Abbey, MD, discusses the most recent research on new injectable medications available for some patients with dry AMD. You can access the full podcast episode here.
About Ashkan Abbey, MD
Dr. Abbey serves as Texas Retina’s Director of Clinical Research for Dallas and cares for patients in our Dallas Main and Rockwall offices. Click here to learn more about him.